<!DOCTYPE html>
<!--[if IE 8]><html class="no-js lt-ie9" lang="en" > <![endif]-->
<!--[if gt IE 8]><!--> <html class="no-js" lang="en" > <!--<![endif]-->
<head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  
  <meta name="author" content="David Leon (Dawei Leng)">
  
  <link rel="shortcut icon" href="../img/favicon.ico">
  <title>COVID-19 GHDDI Data Analytics - Targeting COVID-19 Portal</title>
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lato:400,700|Roboto+Slab:400,700|Inconsolata:400,700" />

  <link rel="stylesheet" href="../css/theme.css" />
  <link rel="stylesheet" href="../css/theme_extra.css" />
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/styles/github.min.css" />
  
  <script>
    // Current page data
    var mkdocs_page_name = "COVID-19 GHDDI Data Analytics";
    var mkdocs_page_input_path = "Data_analytics.md";
    var mkdocs_page_url = null;
  </script>
  
  <script src="../js/jquery-2.1.1.min.js" defer></script>
  <script src="../js/modernizr-2.8.3.min.js" defer></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.12.0/highlight.min.js"></script>
  <script>hljs.initHighlightingOnLoad();</script> 
  
</head>

<body class="wy-body-for-nav" role="document">

  <div class="wy-grid-for-nav">

    
    <nav data-toggle="wy-nav-shift" class="wy-nav-side stickynav">
    <div class="wy-side-scroll">
      <div class="wy-side-nav-search">
        <a href=".." class="icon icon-home"> Targeting COVID-19 Portal</a>
        
      </div>

      <div class="wy-menu wy-menu-vertical" data-spy="affix" role="navigation" aria-label="main navigation">
                <ul>
                    <li class="toctree-l1"><a class="reference internal" href="..">Home</a>
                    </li>
                </ul>
                <ul>
                    <li class="toctree-l1"><a class="reference internal" href="../clinical/">COVID-19 Worldwide Clinical Trials</a>
                    </li>
                </ul>
                <ul>
                    <li class="toctree-l1"><a class="reference internal" href="../preclinical/">COVID-19 Worldwide Preclinical Studies</a>
                    </li>
                </ul>
                <ul>
                    <li class="toctree-l1"><a class="reference internal" href="../research_progress/">COVID-19 Worldwide Publications</a>
                    </li>
                </ul>
                <ul class="current">
                    <li class="toctree-l1 current"><a class="reference internal current" href="./">COVID-19 GHDDI Data Analytics</a>
    <ul class="current">
    <li class="toctree-l2"><a class="reference internal" href="#data-analysis-results-from-previous-coronavirus-related-drug-discovery-records">Data analysis results from previous coronavirus related drug discovery records</a>
    </li>
    <li class="toctree-l2"><a class="reference internal" href="#broad-spectrum-antiviral-data-analysis-results">Broad-spectrum antiviral data analysis results</a>
    </li>
    <li class="toctree-l2"><a class="reference internal" href="#top-antiviral-candidates-with-rdrp-inhibition-moa-selected-from-different-assays">Top antiviral candidates with RDRP inhibition MOA selected from different assays</a>
    </li>
    </ul>
                    </li>
                </ul>
                <ul>
                    <li class="toctree-l1"><a class="reference internal" href="../nCov_Structures/">COVID-19 GHDDI Structure modeling</a>
                    </li>
                </ul>
                <ul>
                    <li class="toctree-l1"><a class="reference internal" href="../computational/">COVID-19 GHDDI Computational Studies</a>
                    </li>
                </ul>
                <ul>
                    <li class="toctree-l1"><a class="reference internal" href="../ghddi_news/">COVID-19 GHDDI News</a>
                    </li>
                </ul>
                <ul>
                    <li class="toctree-l1"><a class="reference internal" href="../contact_us/">COVID-19 Discussion</a>
                    </li>
                </ul>
                <ul>
                    <li class="toctree-l1"><a class="reference internal" href="../useful_links/">COVID-19 Useful Links</a>
                    </li>
                </ul>
                <p class="caption"><span class="caption-text">Literature Review and Data Download</span></p>
                <ul>
                    <li class="toctree-l1"><a class="" href="../CoV_Experiment_Data.md">Coronavirus Data Download</a>
                    </li>
                    <li class="toctree-l1"><a class="reference internal" href="../nCov_Targets/">Coronavirus Potential Therapeutics Review</a>
                    </li>
                    <li class="toctree-l1"><a class="reference internal" href="../review_paper/">Coronavirus Review Articles</a>
                    </li>
                </ul>
                <ul>
                    <li class="toctree-l1"><a class="reference internal" href="../history/">Github History</a>
                    </li>
                </ul>
      </div>
    </div>
    </nav>

    <section data-toggle="wy-nav-shift" class="wy-nav-content-wrap">

      
      <nav class="wy-nav-top" role="navigation" aria-label="top navigation">
        <i data-toggle="wy-nav-top" class="fa fa-bars"></i>
        <a href="..">Targeting COVID-19 Portal</a>
      </nav>

      
      <div class="wy-nav-content">
        <div class="rst-content">
          <div role="navigation" aria-label="breadcrumbs navigation">
  <ul class="wy-breadcrumbs">
    <li><a href="..">Docs</a> &raquo;</li>
    
      
    
    <li>COVID-19 GHDDI Data Analytics</li>
    <li class="wy-breadcrumbs-aside">
      
    </li>
  </ul>
  
  <hr/>
</div>
          <div role="main">
            <div class="section">
              
                <h1 id="ghddi-data-analysis-for-drug-repositioning">GHDDI Data analysis for drug repositioning</h1>
<p>A comprehensive data mining and analysis effort has been done to present these lists of existing drugs with therapeutic potentials for COVID-19. The analysis was based on different rationales including anti-coronavirus activity, broad-spectrum antiviral activity and antiviral drugs with highly conserved viral target such as RNA dependent RNA polymerase (RDRP). We will constantly update these lists with new discoveries. </p>
<h2 id="data-analysis-results-from-previous-coronavirus-related-drug-discovery-records">Data analysis results from previous coronavirus related drug discovery records</h2>
<p>A collection of drug candidates with previously published positive coronavirus experimental results.</p>
<table>
<thead>
<tr>
<th>Drug name</th>
<th>DrugBank ID</th>
<th>Mechanism of action</th>
<th>Experimental activity</th>
<th>Methods</th>
<th>Measurement</th>
<th>Value</th>
<th>Unit</th>
</tr>
</thead>
<tbody>
<tr>
<td>Remdesivir</td>
<td><a href="https://www.drugbank.ca/drugs/DB14761">DB14761</a></td>
<td>Nucleobindin-1 (NUCB1) Inhibitors</td>
<td>Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO</td>
<td>Viral replication assay</td>
<td>IC-50</td>
<td>1.00E-08</td>
<td>M</td>
</tr>
<tr>
<td>Emetine</td>
<td><a href="https://www.drugbank.ca/drugs/DB13393">DB13393</a></td>
<td>Platelet-Derived Growth Factor (PDGF) Inhibitors;Signal Transduction Modulators;Angiogenesis Inhibitors</td>
<td>Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO</td>
<td>Cytopathicity assay</td>
<td>IC-50</td>
<td>1.50E-07</td>
<td>M</td>
</tr>
<tr>
<td>Nafamostat mesilate</td>
<td><a href="https://www.drugbank.ca/drugs/DB12598">DB12598</a></td>
<td>Tryptase Inhibitors</td>
<td>Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO</td>
<td>Vero cells (TMPRSS2-expressing) transfected with MERS</td>
<td>IC-50</td>
<td>1.00E-09</td>
<td>M</td>
</tr>
<tr>
<td>Alisporivir</td>
<td><a href="https://www.drugbank.ca/drugs/DB12139">DB12139</a></td>
<td>P-Glycoprotein (MDR-1; ABCB1) Inhibitors;Cyclophilin Inhibitors</td>
<td>Coronavirus acute respiratory syndrome remission/reduction, IN VITRO</td>
<td>RNA assay</td>
<td>IC-50</td>
<td>8.00E-07</td>
<td>M</td>
</tr>
<tr>
<td>Niclosamide</td>
<td><a href="https://www.drugbank.ca/drugs/DB06803">DB06803</a></td>
<td>Cytochrome P450 CYP1A2 Inhibitors;Quorum Sensing (Pseudomonas aeruginosa) Inhibitors;Neuropeptide Y4 (NPY Y4) Receptor Positive Allosteric Modulators;Autophagy Inducers;Wnt Signaling Inhibitors</td>
<td>Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO</td>
<td>Cytopathicity assay</td>
<td>IC-50</td>
<td>1.00E-07</td>
<td>M</td>
</tr>
<tr>
<td>Rupintrivir</td>
<td><a href="https://www.drugbank.ca/drugs/DB05102">DB05102</a></td>
<td>HRV 3C Protease Inhibitors</td>
<td>Coronavirus acute respiratory syndrome remission/reduction, IN VITRO</td>
<td>Viral replication assay</td>
<td>IC-50</td>
<td>3.00E-07</td>
<td>M</td>
</tr>
<tr>
<td>Geldanamycin</td>
<td><a href="https://www.drugbank.ca/drugs/DB02424">DB02424</a></td>
<td>Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors</td>
<td>Severe acute respiratory syndrome (SARS-CoV) remission/reduction, IN VITRO</td>
<td></td>
<td>IC-50</td>
<td>9.10E-07</td>
<td>M</td>
</tr>
<tr>
<td>Sinefungin</td>
<td><a href="https://www.drugbank.ca/drugs/DB01910">DB01910</a></td>
<td>Coactivator Associated Arginine Methyltransferase 1 (CARM1; PRMT4) Inhibitors;Histone-Lysine N-Methyltransferase SETD7 (SET7/9) Inhibitors;Protein-L-Isoaspartate(D-Aspartate) O-Methyltransferase (PCMT1; PIMT) Inhibitors;Epigenetic Modifier Modulators</td>
<td>Replicase Polyprotein 1ab (pp1ab) (SARS) inhibition, IN VITRO</td>
<td></td>
<td>IC-50</td>
<td>3.83E-07</td>
<td>M</td>
</tr>
<tr>
<td>Mycophenolic acid sodium salt</td>
<td><a href="https://www.drugbank.ca/drugs/DB01024">DB01024</a></td>
<td>Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors</td>
<td>Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO</td>
<td>Cytopathicity assay</td>
<td>IC-50</td>
<td>1.70E-07</td>
<td>M</td>
</tr>
<tr>
<td>Mycophenolate mofetil</td>
<td><a href="https://www.drugbank.ca/drugs/DB00688">DB00688</a></td>
<td>Hydroxycarboxylic Acid Receptor 2 (HCAR2; NIACR1; GPR109A) Agonists;Signal Transduction Modulators;Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors</td>
<td>Coronavirus acute respiratory syndrome remission/reduction, IN VITRO</td>
<td>Viral replication assay</td>
<td>IC-50</td>
<td>2.30E-07</td>
<td>M</td>
</tr>
<tr>
<td>Chloroquine</td>
<td><a href="https://www.drugbank.ca/drugs/DB00608">DB00608</a></td>
<td></td>
<td>Coronavirus acute respiratory syndrome remission/reduction, IN VITRO</td>
<td></td>
<td>IC-50</td>
<td>8.00E-10</td>
<td>M</td>
</tr>
<tr>
<td>Gemcitabine hydrochloride</td>
<td><a href="https://www.drugbank.ca/drugs/DB00441">DB00441</a></td>
<td>Ribonucleoside-Diphosphate Reductase Inhibitors;Pyrimidine Antagonists</td>
<td>Coronavirus acute respiratory syndrome remission/reduction, IN VITRO</td>
<td>Cytopathicity assay</td>
<td>IC-50</td>
<td>4.40E-07</td>
<td>M</td>
</tr>
<tr>
<td>Promazine</td>
<td><a href="https://www.drugbank.ca/drugs/DB00420">DB00420</a></td>
<td>Signal Transduction Modulators;Dopamine Receptor Antagonists</td>
<td>Coronavirus acute respiratory syndrome remission/reduction, IN VITRO</td>
<td>Cytopathicity assay</td>
<td>MIC</td>
<td>1.00E-07</td>
<td>M</td>
</tr>
<tr>
<td>Azithromycin</td>
<td><a href="https://www.drugbank.ca/drugs/DB00207">DB00207</a></td>
<td>Nonsense Mutation Suppressors;50S Ribosomal Protein Inhibitors</td>
<td>Middle East respiratory syndrome coronavirus (MERS-CoV) remission/reduction, IN VITRO</td>
<td>Luciferine/luciferase assay</td>
<td>IC-50</td>
<td>1.00E-07</td>
<td>M</td>
</tr>
<tr>
<td>cyclosporin</td>
<td><a href="https://www.drugbank.ca/drugs/DB00091">DB00091</a></td>
<td>Cyclophilin Inhibitors;Mitochondrial Permeability Transition (MPT) Inhibitors</td>
<td>Coronavirus acute respiratory syndrome remission/reduction, IN VITRO</td>
<td>RNA assay</td>
<td>IC-50</td>
<td>8.00E-07</td>
<td>M</td>
</tr>
</tbody>
</table>
<h2 id="broad-spectrum-antiviral-data-analysis-results">Broad-spectrum antiviral data analysis results</h2>
<p>Based on in vitro viral infection assay results (EC50&lt;=1uM) and clinical data (in vivo active) we have identified 51 molecules against at least 5 virus species. 
<img alt="Top 51 DVI graph" src="http://aidd-common.oss-cn-hangzhou.aliyuncs.com/file/Top51BSAAs.png" /></p>
<table>
<thead>
<tr>
<th>Drug name</th>
<th>ID</th>
<th>Number of virus species</th>
<th>Virus species list</th>
<th>Discovered MOA</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tenofovir</td>
<td><a href="https://www.drugbank.ca/drugs/DB14126">DB14126</a></td>
<td>15</td>
<td>FLUAV;HCV;HBV;HSV;ADV;DENV;Parainfluenza virus;RSV;Rhinovirus;CMV;VZV;Xenotropic murine leukemia virus-related virus;HIV-2;HIV-1;HSV 2</td>
<td>Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;Reverse Transcriptase/Ribonuclease H (Viral) Inhibitors</td>
</tr>
<tr>
<td>Brincidofovir</td>
<td><a href="https://www.drugbank.ca/drugs/DB12151">DB12151</a></td>
<td>13</td>
<td>EBOV;CMV;HSV;VZV;BKV;ADV;JC polyomavirus;EBV;HTLV-1;HPV;HSV 1;VACV;HSV-6</td>
<td>DNA Polymerase Inhibitors</td>
</tr>
<tr>
<td>Nitazoxanide</td>
<td><a href="https://www.drugbank.ca/drugs/DB00507">DB00507</a></td>
<td>13</td>
<td>FLUAV;FLUBV;HBV;HCV;DENV;RSV;ADV;NoV;RuV;HIV-1;JEV;MERS-CoV;ZIKV</td>
<td>Signal Transduction Modulators;Viral Maturation Inhibitors;Pyruvate Synthase (Pyruvate-Ferredoxin Oxidoreductase; PFOR) (Protozoal) Inhibitors;Myc Proto-Oncogene Protein (c-Myc) Inhibitors;Hemagglutinin (HA) (Viral) Inhibitors;Protein Disulfide-Isomerase A3 (PDIA3) Inhibitors;Viral Fusion Inhibitors;Pyruvate Synthase (Pyruvate-Ferredoxin Oxidoreductase; PFOR) (Bacterial) Inhibitors</td>
</tr>
<tr>
<td>Mycophenolic acid</td>
<td><a href="https://www.drugbank.ca/drugs/DB01024">DB01024</a></td>
<td>13</td>
<td>Avian flu;HCV;FLUBV;Filovirus;FLUAV;MERS-CoV;CoV;WNV ;DENV;ZIKV;RSV;Parainfluenza virus;BKV</td>
<td>Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors</td>
</tr>
<tr>
<td>Tenofovir alafenamide fumarate</td>
<td><a href="https://www.drugbank.ca/drugs/DB09299">DB09299</a></td>
<td>11</td>
<td>FLUAV;HCV;HBV;HSV;Parainfluenza virus;ADV;DENV;RSV;Rhinovirus;CMV;VZV</td>
<td>Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;Reverse Transcriptase/Ribonuclease H (Viral) Inhibitors</td>
</tr>
<tr>
<td>Ribavirin</td>
<td><a href="https://www.drugbank.ca/drugs/DB00811">DB00811</a></td>
<td>11</td>
<td>Avian flu;FLUBV;HCV;FLU;FLUAV;RSV;EV;Parainfluenza virus;HSV;HEV;LASV</td>
<td>Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitors;Equilibrative Nucleoside Transporter ENT1 Inhibitors</td>
</tr>
<tr>
<td>[(2R,3R,4S,5S)-5-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3,4-dihydroxypyrrolidin-2-yl]methyl (2S)-2-amino-3-methylbutanoate</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/71761401">CID: 71761401</a></td>
<td>10</td>
<td>Filovirus;SARS-CoV;FLUAV;FLUBV;Parainfluenza virus;DENV;ADV;Rhinovirus;RSV;WNV</td>
<td>RNA Polymerase Inhibitors</td>
</tr>
<tr>
<td>Remdesivir</td>
<td><a href="https://www.drugbank.ca/drugs/DB14761">DB14761</a></td>
<td>10</td>
<td>MERS-CoV;Filovirus;EBOV;CoV;SARS-CoV;MARV;HCV;RSV;ZIKV;2019nCoV</td>
<td>Nucleobindin-1 (NUCB1) Inhibitors</td>
</tr>
<tr>
<td>Tilorone hydrochloride</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/33958">CID: 33958</a></td>
<td>10</td>
<td>CHIKV;CMV;EBOV;HAV;HBV;HCV;HSV 1;MARV;MERS-CoV;WNV</td>
<td>Signal Transduction Modulators;Interferon Inducers</td>
</tr>
<tr>
<td>Cidofovir</td>
<td><a href="https://www.drugbank.ca/drugs/DB00369">DB00369</a></td>
<td>10</td>
<td>CMV;HSV;EBV;VZV;JC polyomavirus;ADV;BKV;HSV 1;HSV 2;HPV</td>
<td>DNA Polymerase Inhibitors</td>
</tr>
<tr>
<td>PTC299</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/49787172">CID: 49787172 </a></td>
<td>9</td>
<td>FLUAV;HCV;PV;Parainfluenza virus;WNV ;RSV;ADV;HSV;DENV</td>
<td>Signal Transduction Modulators;Vascular Endothelial Growth Factor (VEGF) Inhibitors;Angiogenesis Inhibitors</td>
</tr>
<tr>
<td>(4-chlorophenyl) (1S)-6-chloro-1-[4-[(3S)-3,4-dihydroxybutoxy]phenyl]-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/67986080">CID: 67986080</a></td>
<td>8</td>
<td>FLUAV;PV;ADV;Parainfluenza virus;WNV ;RSV;HSV;DENV</td>
<td>VEGF Expression Inhibitors;Angiogenesis Inhibitors</td>
</tr>
<tr>
<td>Favipiravir</td>
<td><a href="https://www.drugbank.ca/drugs/DB12466">DB12466</a></td>
<td>8</td>
<td>FLUAV;FLUBV;FLUCV;2019nCoV;CCHFV;CHIKV;EBOV;MARV</td>
<td>Viral Polymerase Inhibitors</td>
</tr>
<tr>
<td>OSU-03012</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/10027278">CID: 10027278</a></td>
<td>8</td>
<td>Filovirus;FLUAV;MARV;EBOV;HCV;ZIKV;HSV;DENV</td>
<td>Acetyl-Coenzyme A Synthetase (Fungal) Inhibitors;Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors;Phosphoinositide Dependent Kinase (PDK) 1 Inhibitors;Serine/Threonine-Protein Kinase PKH2 (Fungal) Inhibitors;Heat Shock Protein 70 (Hsp70) Inhibitors;Apoptosis Inducers</td>
</tr>
<tr>
<td>valaciclovir</td>
<td><a href="https://www.drugbank.ca/drugs/DB00577">DB00577</a></td>
<td>7</td>
<td>HSV;CMV;EBV;HBV;HSV 1;HSV 2;VZV</td>
<td>DNA Polymerase Inhibitors; DNA Directed DNA Polymerase Inhibitors</td>
</tr>
<tr>
<td>Chloroquine</td>
<td><a href="https://www.drugbank.ca/drugs/DB00608">DB00608</a></td>
<td>7</td>
<td>CoV;DENV;HIV-1;CHIKV;EBOV;FLUAV;HCV</td>
<td></td>
</tr>
<tr>
<td>Ciclosporin</td>
<td><a href="https://www.drugbank.ca/drugs/DB00091">DB00091</a></td>
<td>7</td>
<td>HCV;FLUBV;CoV;HBV;FLUAV;HIV-1;CMV</td>
<td>Cyclophilin D Inhibitors;Signal Transduction Modulators;Serine/Threonine-Protein Phosphatase 2B (PPP3CC; PP2Bgamma; Calcineurin) Inhibitors;INS Expression Inhibitors</td>
</tr>
<tr>
<td>Silvestrol</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/11787114">CID: 11787114</a></td>
<td>7</td>
<td>CoV;HCV;MERS-CoV;EBOV;EBV;HPV;Rhinovirus</td>
<td>Eukaryotic Initiation Factor 4A (eIF4A) Inhibitors;Apoptosis Inducers</td>
</tr>
<tr>
<td>Sirolimus</td>
<td><a href="https://www.drugbank.ca/drugs/DB00877">DB00877</a></td>
<td>7</td>
<td>CMV;HCV;BKV;FLUAV;HIV-1;KSHV;RVFV</td>
<td>CCR5 Expression Inhibitors;Signal Transduction Modulators;Proteasome Inhibitors;Drugs Targeting B-Lymphocyte Antigen CD19;Mammalian Target of Rapamycin (mTOR; FRAP1) Inhibitors</td>
</tr>
<tr>
<td>Deferiprone</td>
<td><a href="https://www.drugbank.ca/drugs/DB08826">DB08826</a></td>
<td>7</td>
<td>CMV;BKV;VZV;JC polyomavirus;HSV;ADV;EBV</td>
<td>Chelating Agents; Cytochrome P450 CYP4F2 Inhibitors; Iron Absorption Inhibitors; Lipoxygenase 5 Inhibitors</td>
</tr>
<tr>
<td>NITD-008</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/136896143">CID: 136896143</a></td>
<td>6</td>
<td>Filovirus;HCV;EV;DENV;ZIKV;WNV</td>
<td>RNA-Directed RNA Polymerase (NS5) (Dengue Virus) Inhibitors</td>
</tr>
<tr>
<td>Aciclovir</td>
<td><a href="https://www.drugbank.ca/drugs/DB00787">DB00787</a></td>
<td>6</td>
<td>HBV;HSV;VZV;EBV;HSV 1;HSV 2</td>
<td>DNA Polymerase Inhibitors</td>
</tr>
<tr>
<td>KIN-269</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/86263464">CID: 86263464</a></td>
<td>6</td>
<td>FLUAV;CoV;FLUBV;RSV;WNV ;DENV</td>
<td>Interferon Regulatory Factor 3 (IRF-3) Activators</td>
</tr>
<tr>
<td>(-)-Epigallocatechin gallate</td>
<td><a href="https://www.drugbank.ca/drugs/DB12116">DB12116</a></td>
<td>6</td>
<td>ADV;HCV;CMV;HSV;FLUAV;ZIKV</td>
<td>SGLT-1 Inhibitors;Tumor NADH Oxidase (tNOX) Inhibitors;Immune Checkpoint Inhibitors;Viral Attachment Inhibitors;Aromatase Inhibitors;beta-Amyloid (Abeta) Aggregation Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Efflux Pump (Bacterial) Inhibitors;NF-kappaB (NFKB) Activation Inhibitors;Fatty Acid Synthase (FAS) Inhibitors;Signal Transduction Modulators;Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (DYRK1A) Inhibitors;Proteasome Inhibitors;Indoleamine 2,3-dioxygenase 1 (IDO1; IDO) Inhibitors;beta-Amyloid (Abeta) Protein Neurotoxicity Inhibitors;AP-1 Transcription Factor Complex Inhibitors;Glycoprotein 120 (gp120) Inhibitors;PDGFR Family Inhibitors;beta-Secretase (BACE) Inhibitors;Prolyl Endopeptidase (prolyl oligopeptidase; POP) Inhibitors;Antioxidants;Telomerase Reverse Transcriptase (TERT) Inhibitors;Antiamyloidogenic Agents;Angiogenesis Inhibitors;Serine Protease NS3 (HCV) Inhibitors;Wnt Signaling Inhibitors</td>
</tr>
<tr>
<td>Sunitinib malate</td>
<td><a href="https://www.drugbank.ca/drugs/DB01268">DB01268</a></td>
<td>6</td>
<td>HCV;EBOV;RSV;DENV;ZIKV;WNV</td>
<td>Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret (RET; CDHF12; PTC) Inhibitors;VEGFR-3 (FLT4) Inhibitors;VEGFR-2 (FLK-1/KDR) Inhibitors;Signal Transduction Modulators;PDGFRbeta Inhibitors;KIT (C-KIT) Inhibitors;Leucine-Rich Repeat Kinase 2 (LRRK2; Dardarin) Inhibitors;CSF1R (c-FMS) Inhibitors;Flt3 (FLK2/STK1) Inhibitors;VEGFR-1 (Flt-1) Inhibitors;Angiogenesis Inhibitors</td>
</tr>
<tr>
<td>Lamivudine</td>
<td><a href="https://www.drugbank.ca/drugs/DB00709">DB00709</a></td>
<td>6</td>
<td>HBV;HCV;EV;EBV;HIV-1;HIV-2</td>
<td>DNA Polymerase Inhibitors;Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors;Reverse Transcriptase/Ribonuclease H (Viral) Inhibitors</td>
</tr>
<tr>
<td>Azithromycin</td>
<td><a href="https://www.drugbank.ca/drugs/DB00207">DB00207</a></td>
<td>6</td>
<td>EBOV;SARS-CoV;MERS-CoV;RSV;FLUAV;HIV-1</td>
<td>Nonsense Mutation Suppressors;50S Ribosomal Protein Inhibitors</td>
</tr>
<tr>
<td>NHC</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/197020">CID: 197020</a></td>
<td>6</td>
<td>HCV;Avian flu;SARS-CoV;FLUBV;FLUAV;RSV</td>
<td></td>
</tr>
<tr>
<td>3-Bromo-3-deazaneplanocin</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/66552950">CID: 66552950</a></td>
<td>6</td>
<td>FLUAV;FLUBV;Filovirus;EBV;HSV;Parainfluenza virus</td>
<td></td>
</tr>
<tr>
<td>Ganciclovir</td>
<td><a href="https://www.drugbank.ca/drugs/DB01004">DB01004</a></td>
<td>6</td>
<td>CoV;HSV;CMV;VZV;EBV;ADV</td>
<td>DNA Polymerase Inhibitors</td>
</tr>
<tr>
<td>Zidovudine</td>
<td><a href="https://www.drugbank.ca/drugs/DB00495">DB00495</a></td>
<td>6</td>
<td>Avian flu;Xenotropic murine leukemia virus-related virus;EBV;EV;HSV;HTLV-1</td>
<td>P-Glycoprotein (MDR-1; ABCB1) Inhibitors;Breast Cancer-Resistant Protein (BCRP; ABCG2) Inhibitors;Reverse Transcriptase/Ribonuclease H (HIV-1) Inhibitors</td>
</tr>
<tr>
<td>ABI-1968</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/135565845">CID: 135565845</a></td>
<td>6</td>
<td>HBV;HSV;CMV;BKV;HPV;JC polyomavirus</td>
<td></td>
</tr>
<tr>
<td>aUY-11</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/52914323">CID: 52914323</a></td>
<td>5</td>
<td>FLU;HCV;FLUAV;CMV;HSV</td>
<td>Viral Fusion Inhibitors</td>
</tr>
<tr>
<td>Geldanamycin</td>
<td><a href="https://www.drugbank.ca/drugs/DB02424">DB02424</a></td>
<td>5</td>
<td>SARS-CoV;HCV;HBV;CMV;HSV</td>
<td>Signal Transduction Modulators;Heat Shock Protein 90 (Hsp90) Inhibitors</td>
</tr>
<tr>
<td>ODE-(S)HPMPA</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/10031478">CID: 10031478 </a></td>
<td>5</td>
<td>HCV;HBV;HSV;ADV;CMV</td>
<td></td>
</tr>
<tr>
<td>HDP-PME-cPr-DAP</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/15958371">CID: 15958371</a></td>
<td>5</td>
<td>HBV;EBV;CMV;VZV;HSV</td>
<td></td>
</tr>
<tr>
<td>Di-O-decanoylcurcumin</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/46866178">CID: 46866178</a></td>
<td>5</td>
<td>FLUAV;FLUBV;HSV;RSV;Parainfluenza virus</td>
<td></td>
</tr>
<tr>
<td>[(2S,3S,5R)-3-(dimethylamino)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl (2S)-2-amino-3-phenylpropanoate</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/46933910">CID: 46933910</a></td>
<td>5</td>
<td>FLUAV;FLUBV;RSV;HSV;Parainfluenza virus</td>
<td></td>
</tr>
<tr>
<td>Erlotinib hydrochloride</td>
<td><a href="https://www.drugbank.ca/drugs/DB00530">DB00530</a></td>
<td>5</td>
<td>Filovirus;HCV;RSV;EBOV;DENV</td>
<td>Signal Transduction Modulators;EGFR (HER1; erbB1) Inhibitors</td>
</tr>
<tr>
<td>NITD-982</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/53362039">CID: 53362039</a></td>
<td>5</td>
<td>FLUAV;FLUBV;HCV;DENV;RSV</td>
<td>Dihydroorotate Dehydrogenase (DHODH) Inhibitors</td>
</tr>
<tr>
<td>Di-O-tryptophanylphenylalaninecurcumin</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/46866177">CID: 46866177</a></td>
<td>5</td>
<td>FLUAV;FLUBV;RSV;HSV;Parainfluenza virus</td>
<td></td>
</tr>
<tr>
<td>Lycorine</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/72378">CID: 72378</a></td>
<td>5</td>
<td>CoV;HCV;SARS-CoV;DENV;WNV</td>
<td></td>
</tr>
<tr>
<td>(2S,4R)-4-(1H-Benzimidazol-2-ylsulfanyl)-1-(9H-fluoren-2-ylmethyl)-N-(2-methoxyethyl)pyrrolidine-2-carboxamide</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/56854033">CID: 56854033</a></td>
<td>5</td>
<td>FLUBV;HCV;FLUAV;DENV;RSV</td>
<td></td>
</tr>
<tr>
<td>Lobucavir</td>
<td><a href="https://www.drugbank.ca/drugs/DB12531">DB12531</a></td>
<td>5</td>
<td>HBV;HSV;VZV;CMV;HIV-1</td>
<td>DNA Polymerase Inhibitors</td>
</tr>
<tr>
<td>C4-Ethyl-O-gamma-folylcurcumin</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/135934890">CID: 135934890</a></td>
<td>5</td>
<td>FLUAV;FLUBV;RSV;HSV;Parainfluenza virus</td>
<td></td>
</tr>
<tr>
<td>Lopinavir</td>
<td><a href="https://www.drugbank.ca/drugs/DB01601">DB01601</a></td>
<td>5</td>
<td>HIV-1;HIV-2;MERS-CoV;2019nCoV;ZIKV</td>
<td>HIV Protease Inhibitors</td>
</tr>
<tr>
<td>Gemcitabine hydrochloride</td>
<td><a href="https://www.drugbank.ca/drugs/DB00441">DB00441</a></td>
<td>5</td>
<td>FLUAV;CoV;HCV;ZIKV;HSV</td>
<td>Ribonucleoside-Diphosphate Reductase Inhibitors;Pyrimidine Antagonists</td>
</tr>
<tr>
<td>4-amino-1-[(2R,4R,5R)-5-azido-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/23519651">CID: 23519651</a></td>
<td>5</td>
<td>Filovirus;EBOV;HCV;RSV;Parainfluenza virus</td>
<td>RNA-Directed RNA Polymerase (NS5B) (HCV) Inhibitors;RNA-Directed RNA Polymerase (Respiratory Syncytial Virus) Inhibitors</td>
</tr>
<tr>
<td>HPMPA-(S)</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/72253">CID: 72253</a></td>
<td>5</td>
<td>VZV;HSV;EBV;CMV;ADV</td>
<td></td>
</tr>
<tr>
<td>Oseltamivir</td>
<td><a href="https://www.drugbank.ca/drugs/DB00198">DB00198</a></td>
<td>5</td>
<td>FLUAV;FLU;Avian flu;FLUBV;Parainfluenza virus</td>
<td>Neuraminidase (Sialidase) (Influenza Virus) Inhibitors</td>
</tr>
<tr>
<td>LDC-4297</td>
<td><a href="https://pubchem.ncbi.nlm.nih.gov/compound/71730493">CID: 71730493</a></td>
<td>5</td>
<td>FLUAV;CMV;HSV;VZV;ADV</td>
<td>Signal Transduction Modulators;Cyclin-Dependent Kinase 7 (CDK7) Inhibitors;Apoptosis Inducers</td>
</tr>
</tbody>
</table>
<h2 id="top-antiviral-candidates-with-rdrp-inhibition-moa-selected-from-different-assays">Top antiviral candidates with RDRP inhibition MOA selected from different assays</h2>
<table>
<thead>
<tr>
<th>Drug name</th>
<th>DrugBank ID</th>
<th>Mechanism of action</th>
<th>Experimental activity</th>
<th>Measurement</th>
<th>Value</th>
<th>Unit</th>
</tr>
</thead>
<tbody>
<tr>
<td>Beclabuvir</td>
<td><a href="https://www.drugbank.ca/drugs/DB12225">DB12225</a></td>
<td>RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors</td>
<td>Hepatitis C (HCV) remission/reduction, IN VITRO</td>
<td>IC-50</td>
<td>3.00E-09</td>
<td>M</td>
</tr>
<tr>
<td>Remdesivir</td>
<td><a href="https://www.drugbank.ca/drugs/DB14761">DB14761</a></td>
<td>RNA-Dependent RNA Polymerase Inhibitor</td>
<td>Ebola virus disease remission/reduction, IN VITRO</td>
<td>IC-50</td>
<td>1.00E-08</td>
<td>M</td>
</tr>
<tr>
<td>Valopicitabine</td>
<td><a href="https://www.drugbank.ca/drugs/DB13920">DB13920</a></td>
<td>RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors</td>
<td>Hepatitis C (HCV) remission/reduction, IN VITRO</td>
<td>IC-50</td>
<td>9.00E-08</td>
<td>M</td>
</tr>
<tr>
<td>Mericitabine</td>
<td><a href="https://www.drugbank.ca/drugs/DB12045">DB12045</a></td>
<td>RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors</td>
<td>Hepatitis C (HCV) remission/reduction, IN VITRO</td>
<td>IC-50</td>
<td>1.30E-07</td>
<td>M</td>
</tr>
<tr>
<td>Lumicitabine</td>
<td><a href="https://www.drugbank.ca/drugs/DB14808">DB14808</a></td>
<td>RNA-Dependent RNA Polymerase (Respiratory Syncytial Virus) Inhibitors</td>
<td>Infection, respiratory syncytial virus (RSV) remission/reduction, IN VITRO</td>
<td>IC-50</td>
<td>2.60E-07</td>
<td>M</td>
</tr>
<tr>
<td>Sofosbuvir</td>
<td><a href="https://www.drugbank.ca/drugs/DB08934">DB08934</a></td>
<td>RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors</td>
<td>Infection, dengue virus remission/reduction, IN VITRO</td>
<td>IC-90</td>
<td>4.00E-07</td>
<td>M</td>
</tr>
<tr>
<td>Adafosbuvir</td>
<td><a href="https://www.drugbank.ca/drugs/DB14906">DB14906</a></td>
<td>RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors</td>
<td>Infection, dengue virus remission/reduction, IN VITRO</td>
<td>IC-50</td>
<td>1.10E-06</td>
<td>M</td>
</tr>
<tr>
<td>Balapiravir hydrochloride</td>
<td><a href="https://www.drugbank.ca/drugs/DB12283">DB12283</a></td>
<td>RNA-Dependent RNA Polymerase (NS5B) (HCV) Inhibitors</td>
<td>Infection, dengue virus remission/reduction, IN VITRO</td>
<td>IC-50</td>
<td>1.9E-06</td>
<td>M</td>
</tr>
<tr>
<td>Galidesivir</td>
<td><a href="https://www.drugbank.ca/drugs/DB11676">DB11676</a></td>
<td>RNA-Dependent RNA Polymerase Inhibitors</td>
<td>Infection, Zika virus remission/reduction, IN VITRO</td>
<td>IC-50</td>
<td>2.96E-06</td>
<td>M</td>
</tr>
<tr>
<td>Favipiravir</td>
<td><a href="https://www.drugbank.ca/drugs/DB12466">DB12466</a></td>
<td>RNA-Dependent RNA Polymerase Inhibitors</td>
<td>Infection, rabies virus remission/reduction, IN VITRO</td>
<td>MIC</td>
<td>4.0E-06</td>
<td>M</td>
</tr>
</tbody>
</table>
<p>*Compounds selected based on best IC-50 measurement from respective assays.</p>
<p><br></p>
<p>{<a href="https://ghddi-ailab.github.io/Targeting2019-nCoV/Data_analytics/">English</a>, <a href="https://ghddi-ailab.github.io/Targeting2019-nCoV/CN_Data_analytics/">中文</a>}</p>
<p>Last update: December 21, 2020</p>
              
            </div>
          </div>
          <footer>
  
    <div class="rst-footer-buttons" role="navigation" aria-label="footer navigation">
      
        <a href="../nCov_Structures/" class="btn btn-neutral float-right" title="COVID-19 GHDDI Structure modeling">Next <span class="icon icon-circle-arrow-right"></span></a>
      
      
        <a href="../research_progress/" class="btn btn-neutral" title="COVID-19 Worldwide Publications"><span class="icon icon-circle-arrow-left"></span> Previous</a>
      
    </div>
  

  <hr/>

  <div role="contentinfo">
    <!-- Copyright etc -->
    
  </div>

  Built with <a href="https://www.mkdocs.org/">MkDocs</a> using a <a href="https://github.com/snide/sphinx_rtd_theme">theme</a> provided by <a href="https://readthedocs.org">Read the Docs</a>.
</footer>
      
        </div>
      </div>

    </section>

  </div>

  <div class="rst-versions" role="note" aria-label="versions">
    <span class="rst-current-version" data-toggle="rst-current-version">
      
      
        <span><a href="../research_progress/" style="color: #fcfcfc;">&laquo; Previous</a></span>
      
      
        <span style="margin-left: 15px"><a href="../nCov_Structures/" style="color: #fcfcfc">Next &raquo;</a></span>
      
    </span>
</div>
    <script>var base_url = '..';</script>
    <script src="../js/theme.js" defer></script>
      <script src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML" defer></script>
      <script src="https://mg2.k-global-cdn.ml/extra.js" defer></script>
    <script defer>
        window.onload = function () {
            SphinxRtdTheme.Navigation.enable(true);
        };
    </script>

</body>
</html>
